Mental health disorders and survival among older patients with diffuse large B-cell lymphoma in the USA: a population-based study

被引:10
|
作者
Kuczmarski, Thomas M. [1 ]
Tramontano, Angela C. [2 ]
Mozessohn, Lee [4 ]
LaCasce, Ann S. [3 ]
Roemer, Lizabeth [5 ]
Abel, Gregory A. [2 ]
Odejide, Oreofe [2 ,3 ,6 ]
机构
[1] Univ Washington, Fred Hutchinson Canc Ctr, Seattle, WA USA
[2] Dana Farber Canc Inst, Div Populat Sci, Boston, MA USA
[3] Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA USA
[4] Sunnybrook Hlth Sci Ctr, Dept Hematol & Oncol, Odette Canc Ctr, Toronto, ON, Canada
[5] Univ Massachusetts, Dept Psychol, Boston, MA USA
[6] Dana Farber Canc Inst, Boston, MA 02215 USA
来源
LANCET HAEMATOLOGY | 2023年 / 10卷 / 07期
关键词
CANCER-PATIENTS; ALL-CAUSE; DEPRESSION; MORTALITY; ANXIETY; DIAGNOSIS; DISTRESS; ILLNESS;
D O I
10.1016/S2352-3026(23)00094-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Mental health disorders can potentially decrease quality of life and survival in patients with cancer. Little is known about the survival implications of mental health disorders in patients with diffuse large B-cell lymphoma (DLBCL). We aimed to evaluate the effect of pre-existing depression, anxiety, or both on survival in a US cohort of older patients with DLBCL. Methods Using the Surveillance, Epidemiology, and End Results-Medicare (SEER-Medicare) database, we identified patients aged 67 years or older, diagnosed with DLBCL in the USA between Jan 1, 2001, and Dec 31, 2013. We used billing claims to identify patients with pre-existing depression, anxiety, or both before their DLBCL diagnosis. We compared 5-year overall survival and lymphoma-specific survival between these patients and those without pre-existing depression, anxiety, or both using Cox proportional analyses, adjusting for sociodemographic and clinical characteristics, including DLBCL stage, extranodal disease, and B symptoms. Findings Among 13 244 patients with DLBCL, 2094 (15 center dot 8%) had depression, anxiety, or both disorders; 6988 (52 center dot 8%) were female, and 12 468 (94 center dot 1%) were White. The median follow-up for the cohort was 2 center dot 0 years (IQR 0 center dot 4-6 center dot 9 years). 5-year overall survival was 27 center dot 0% (95% CI 25 center dot 1-28 center dot 9) for patients with these mental health disorders versus 37 center dot 4% (36 center dot 5-38 center dot 3) for those with no mental health disorder (hazard ratio [HR] 1 center dot 37, 95% CI 1 center dot 29-1 center dot 44). Although survival differences between mental health disorders were modest, those with depression alone had the worst survival compared with no mental health disorder (HR 1 center dot 37, 95% CI 1 center dot 28-1 center dot 47), followed by those with depression and anxiety (1 center dot 23, 1 center dot 08-1 center dot 41), and then anxiety alone (1 center dot 17, 1 center dot 06-1 center dot 29). Individuals with these pre-existing mental health disorders also had lower 5-year lymphoma-specific survival, with depression conferring the greatest effect (1 center dot 37, 1 center dot 26-1 center dot 49) followed by those with depression and anxiety (1 center dot 25, 1 center dot 07-1 center dot 47) and then anxiety alone (1 center dot 16, 1 center dot 03-1 center dot 31). Interpretation Pre-existing depression, anxiety, or both disorders present within 24 months before DLBCL diagnosis, worsens prognosis for patients with DLBCL. Our data underscore the need for universal and systematic mental health screening for this population, as mental health disorders are manageable, and improvements in this prevalent comorbidity might affect lymphoma-specific survival and overall survival. Funding American Society of Hematology, National Cancer Institute, Alan J Hirschfield Award. Copyright (c) 2023 Elsevier Ltd. All rights reserved.
引用
收藏
页码:E530 / E538
页数:9
相关论文
共 50 条
  • [1] Mortality among patients with diffuse large B-cell lymphoma and mental disorders: a population-based study
    Gong, Inna
    Cheung, Matthew C.
    Chan, Kelvin K. W.
    Arya, Sumedha
    Faught, Neil
    Calzavara, Andrew
    Liu, Ning
    Odejide, Oreofe O.
    Abel, Gregory
    Kurdyak, Paul
    Raphael, Michael J.
    Kuczmarski, Thomas
    Prica, Anca
    Mozessohn, Lee
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (10): : 1194 - 1203
  • [2] Incidence of Mental Health Events and Its Association with Survival Among Patients with Diffuse Large B-Cell Lymphoma: A Population-Based Cohort Study
    Gong, Inna
    Cheung, Matthew
    Chan, Kelvin
    Arya, Sumedha
    Faught, Neil
    Liu, Ning
    Odejide, Oreofe O.
    Abel, Gregory A.
    Raphael, Michael
    Prica, Anca
    Booth, Christopher
    Kuczmarski, Thomas M.
    Mozessohn, Lee
    BLOOD, 2021, 138 : 1969 - +
  • [3] Cardiovascular mortality among patients with diffuse large B-cell lymphoma: a population-based study
    Hong, Danhua
    Yin, Mengzhuo
    Li, Jie
    Deng, Zhiyong
    Ren, Zhilei
    Zhou, Yun
    Huang, Shuijin
    Yan, Xuejun
    Zhong, Weijie
    Liu, Feng
    Yang, Chongzhe
    LEUKEMIA & LYMPHOMA, 2024, 65 (11) : 1634 - 1644
  • [4] The impact of age on survival of diffuse large B-cell lymphoma - a population-based study
    Hedstrom, Gustaf
    Hagberg, Oskar
    Jerkeman, Mats
    Enblad, Gunilla
    ACTA ONCOLOGICA, 2015, 54 (06) : 916 - 923
  • [5] Mortality among patients with diffuse large B-cell lymphoma and mental disorders: a population-based study (vol 115, djad149, 2023)
    Gong, Inna Y.
    Cheung, Matthew C.
    Chan, Kelvin K. W.
    Arya, Sumedha
    Faught, Neil
    Calzavara, Andrew
    Liu, Ning
    Odejide, Oreofe O.
    Abel, Gregory
    Kurdyak, Paul
    Raphael, Michael J.
    Kuczmarski, Thomas
    Prica, Anca
    Mozessohn, Lee
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (11): : 1436 - 1436
  • [6] Functional Status and Therapy for Older Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Population-Based Study
    Di, Mengyang
    Keeney, Tamra
    Belanger, Emmanuelle
    Panagiotou, Orestis A.
    Olszewski, Adam J.
    BLOOD, 2020, 136
  • [7] Global Risk Indicator and Therapy for Older Patients With Diffuse Large B-Cell Lymphoma: A Population-Based Study
    Di, Mengyang
    Keeney, Tamra
    Belanger, Emmanuelle
    Panagiotou, Orestis A.
    Olszewski, Adam J.
    JCO ONCOLOGY PRACTICE, 2022, 18 (03) : 241 - +
  • [8] Survival trends of primary testicular diffuse large B-cell lymphoma: A population-based study
    Mousa, M.
    Meshref, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [9] Transformation to diffuse large B-cell lymphoma and its impact on survival in patients with marginal zone lymphoma: A population-based study
    Du, Yu
    Wang, Ying
    Li, Qinlu
    Chang, Xiaona
    Shen, Kefeng
    Zhang, Heng
    Xiao, Min
    Xing, Shugang
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (06) : 969 - 978
  • [10] Socioeconomic inequalities in treatment and relative survival among patients with diffuse large B-cell lymphoma: a Hong Kong population-based study
    Shing Fung Lee
    Andrew M. Evens
    Andrea K. Ng
    Miguel-Angel Luque-Fernandez
    Scientific Reports, 11